sb 203580 has been researched along with krn 7000 in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (krn 7000) | Trials (krn 7000) | Recent Studies (post-2010) (krn 7000) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 856 | 23 | 464 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bisch, SP; Haeryfar, SM; Hayatsu, J; Leon-Ponte, M; Maleki Vareki, S; Mazzuca, DM; Stuart, JK | 1 |
Chung, YS; Jeong, YH; Kim, HS; Kim, Y; Park, SB; Song, H | 1 |
2 other study(ies) available for sb 203580 and krn 7000
Article | Year |
---|---|
Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Topics: Animals; Anthracenes; Antibodies; Antigen Presentation; Antigens; Antigens, CD1d; CD3 Complex; Cytokines; Down-Regulation; Enzyme Inhibitors; Flavonoids; Galactosylceramides; Imidazoles; Interferon-gamma; Interleukin-2; Interleukin-4; Mice; Mice, Inbred C57BL; Natural Killer T-Cells; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Receptors, Antigen, T-Cell; Spleen | 2010 |
Anti-inflammatory effects of α-galactosylceramide analogs in activated microglia: involvement of the p38 MAPK signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Cells, Cultured; Cyclooxygenase 2; DNA; Galactosylceramides; Gene Expression Regulation, Enzymologic; Imidazoles; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Microglia; NF-kappa B; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Transcription Factor AP-1 | 2014 |